Literature DB >> 25606666

The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009.

A K Chandran1, P D Udayakumar, C S Crowson, K J Warrington, E L Matteson.   

Abstract

OBJECTIVE: To assess the incidence of giant cell arteritis (GCA) in the era from 2000 to 2009.
METHOD: We extended the previously identified population-based cohort of Olmsted County, Minnesota residents who fulfilled 1990 American College of Rheumatology (ACR) criteria for GCA for earlier decades during 1950-1999.
RESULTS: In 2000-2009, 74 cases of GCA were identified (mean age 78.1 years; 80% women; 79% temporal artery biopsy positive; seven included based on radiological criteria). The incidence of GCA was 19.8 per 100,000 population.
CONCLUSIONS: The GCA incidence rates have remained steady since 1970 and the age at incidence, which was progressively increasing, seems to have reached a plateau.

Entities:  

Mesh:

Year:  2015        PMID: 25606666      PMCID: PMC4431922          DOI: 10.3109/03009742.2014.982701

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  15 in total

1.  Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey.

Authors:  Shigeto Kobayashi; Tetsuro Yano; Yoshifuji Matsumoto; Fujio Numano; Nobuyuki Nakajima; Keishu Yasuda; Chikao Yutani; Toshiko Nakayama; Akiko Tamakoshi; Takashi Kawamura; Yoshiyuki Ohno; Yutaka Inaba; Hiroshi Hashimoto
Journal:  Arthritis Rheum       Date:  2003-08-15

2.  The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations.

Authors:  M Bas-Lando; G S Breuer; Y Berkun; M Mates; M Sonnenblick; G Nesher
Journal:  Clin Exp Rheumatol       Date:  2007 Jan-Feb       Impact factor: 4.473

3.  Increase in age at onset of giant cell arteritis: a population-based study.

Authors:  Tanaz A Kermani; Valentin S Schäfer; Cynthia S Crowson; Gene G Hunder; Sherine E Gabriel; Eric L Matteson; Kenneth J Warrington
Journal:  Ann Rheum Dis       Date:  2009-10-22       Impact factor: 19.103

4.  The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis.

Authors:  Anmar M Abdul-Rahman; Anthony C B Molteno; Tui H Bevin
Journal:  N Z Med J       Date:  2011-02-11

5.  Epidemiology of biopsy-proven giant cell arteritis in South Australia.

Authors:  E Dunstan; S L Lester; M Rischmueller; T Dodd; R Black; M Ahern; L G Cleland; P Roberts-Thomson; C L Hill
Journal:  Intern Med J       Date:  2014-01       Impact factor: 2.048

6.  Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.

Authors:  Aladdin J Mohammad; Jan-Åke Nilsson; Lennart T H Jacobsson; Peter A Merkel; Carl Turesson
Journal:  Ann Rheum Dis       Date:  2014-01-17       Impact factor: 19.103

7.  The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Authors:  V Petursdottir; H Johansson; E Nordborg; C Nordborg
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

8.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

9.  The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern.

Authors:  C Salvarani; S E Gabriel; W M O'Fallon; G G Hunder
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

10.  Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.

Authors:  Carlo Salvarani; Cynthia S Crowson; W Michael O'Fallon; Gene G Hunder; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2004-04-15
View more
  22 in total

1.  Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.

Authors:  P Elfving; O Marjoniemi; H Niinisalo; A Kononoff; L Arstila; E Savolainen; J Rutanen; O Kaipiainen-Seppänen
Journal:  Rheumatol Int       Date:  2016-04-06       Impact factor: 2.631

Review 2.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

3.  Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.

Authors:  Cynthia S Crowson; Eric L Matteson
Journal:  Semin Arthritis Rheum       Date:  2017-04-07       Impact factor: 5.532

4.  Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings.

Authors:  Jaume Mestre-Torres; Marc Simó-Perdigó; Fernando Martínez-Valle; Ignacio Navales; Jose Loureiro-Amigo; Roser Solans-Laque
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-12       Impact factor: 9.236

5.  Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort.

Authors:  Thomas D Garvey; Matthew J Koster; Cynthia S Crowson; Kenneth J Warrington
Journal:  Semin Arthritis Rheum       Date:  2021-09-27       Impact factor: 5.532

6.  Incidence of giant cell arteritis in six districts of Paris, France (2015-2017).

Authors:  Solange Gonzalez Chiappe; Sarah Lechtman; Carla Soledad Maldini; Arsène Mekinian; Thomas Papo; Thomas Sené; Alfred Daniel Mahr
Journal:  Rheumatol Int       Date:  2022-07-12       Impact factor: 3.580

7.  The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?

Authors:  C John Michet; Cynthia S Crowson; Sara J Achenbach; Eric L Matteson
Journal:  J Rheumatol       Date:  2015-08-01       Impact factor: 4.666

8.  Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.

Authors:  John J Chen; Jacqueline A Leavitt; Chengbo Fang; Cynthia S Crowson; Eric L Matteson; Kenneth J Warrington
Journal:  Ophthalmology       Date:  2016-06-11       Impact factor: 12.079

9.  The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.

Authors:  Alvise Berti; Divi Cornec; Cynthia S Crowson; Ulrich Specks; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

10.  Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.

Authors:  Donatienne de Mornac; Olivier Espitia; Antoine Néel; Jérôme Connault; Agathe Masseau; Alexandra Espitia-Thibault; Mathieu Artifoni; Aurélie Achille; Anaïs Wahbi; Mathieu Lacou; Cécile Durant; Pierre Pottier; François Perrin; Julie Graveleau; Mohamed Hamidou; Jean-Benoit Hardouin; Christian Agard
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-18       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.